The CESAR trial showed improved survival at 6 months (63% vs 47%) in adults with severe acute respiratory failure
EOLIA trial: early use of ECMO did not significantly improve mortality at 60 days in patients with severe ARDS, but when used as a rescue modality ECMO may help improve survival
